Detection of isolated tumor cells in peripheral blood and in BM: Evaluation of a new enrichment method

Cytotherapy

Volumn 6, Issue 3, 2004, Pages 244-252

  Naume, Bjørn ^a   Borgen, E ^a   Tossvik S ^a   Pavlak, N ^b   Oates, D ^b   Nesland, J M ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Applied Imaging Corp   (United States)

Author keywords

Bone marrow; Carcinoma patients; Enrichment; Isolated tumor cells; Peripheral blood

Indexed keywords

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BLOOD VOLUME; BONE MARROW; BREAST CARCINOMA; CANCER PATIENT; CELL ISOLATION; CELL SEPARATION; COLORECTAL CANCER; CONTROLLED STUDY; ENRICHMENT CULTURE; ERYTHROPENIA; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; LEUKOPENIA; MAJOR CLINICAL STUDY; PROSTATE CARCINOMA; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; ROSETTE TEST; SENSITIVITY ANALYSIS; TUMOR CELL; TUMOR VOLUME; WORKLOAD;

EID: 3042849126     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240410006086     Document Type: Article

References (25)

1. Lindemann F, Schlimok G, Dirschedl P et al. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992;340:685-9.
2. Harbeck N, Untch M, Pache L et al. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 1994;69:566-71.
3. Diel IJ, Kaufmann M, Costa SD et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status. J Natl Cancer Inst 1996;88:1652-8.
4. Braun S, Pantel K, Muller P et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000;342:525-33.
5. Gebauer G, Fehm T, Merkle E et al. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up. J Clin Oncol 2001;19:3669-74.
6. Wiedswang G, Borgen E, Kåresen R et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol 2003;21:3469-78.
7. Pantel K, Izbicki J, Passlick B et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 1996;347:649-53.
8. Naume B, Borgen E, Beiske K et al. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hematother 1997;6:103-13.
9. Naume B, Borgen E, Nesland JM et al. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer 1998;78:556-60.
10. Marth C, Kisic J, Kaern J et al. Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis. Cancer 2002;94:707-12.
11. Brandt B, Junker R, Griwatz C et al. Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res 1996;56:4556-61.
12. Griwatz C, Brandt B, Assmann G et al. An immunological enrichment method for epithelial cells from peripheral blood. J Immunol Methods 1995;183:251-65.
13. Denis MG, Lipart C, Leborgne J et al. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer 1997;74:540-4.
14. Martin VM, Siewert C, Scharl A et al. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 1998;26:252-64.
15. Racila E, Euhus D, Weiss AJ et al. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998;95:4589-94.
16. Slade MJ, Smith BM, Sinnett HD et al. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol 1999;17:870-9.
17. Molnar B, Ladanyi A, Tanko L et al. Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin Cancer Res 2001;7:4080- 5.
18. Aerts J, Wynendaele W, Paridaens R et al. A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood. Ann Oncol 2001;12:39-46.
19. Stathopoulou A, Vlachonikolis I, Mavroudis D et al. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol 2002;20:3404-12.
20. Naume B, Borgen E, Kvalheim G et al. Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. Clin Cancer Res 2001;7: 4122-9.
21. Borgen E, Beiske K, Trachsel S et al. Immunocytochemical detection of isolated epithelial cells in bone marrow. Unspecific staining and contribution by plasma cells directly reactive to alkaline phosphatase. J Pathol 1998;185:427-34.
22. Borgen E, Naume B, Nesland JM et al. Standarization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 1998;1:377-88.
23. Lin JC, Chen KY, Wang WY et al. Evaluation of cytokeratin-19 mRNA as a rumor market in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy. Int J Cancer 2002;97:548-53.
24. Mansi JL, Easton D, Berger U et al. Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur J Cancer 1991;27:1552-5.
25. Cote RJ, Rosen PP, Lesser ML et al. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991;9:1749-56.